Jing-Huan Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jing-Huan Wang has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Pentti Tuohimaa
4 shared publicationsAllan V. Kalueff
1 shared publicationAnna Minasyan
1 shared publicationTiina Keisala
1 shared publicationTiina Solakivi
1 shared publication
Latest Publications
- 1 February 2009
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 113 (3-5) , 222-226
Serum cholesterol and expression of ApoAI, LXRβ and SREBP2 in vitamin D receptor knock-out mice
- 1 February 2009
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 113 (3-5) , 222-226
Serum cholesterol and expression of ApoAI, LXRβ and SREBP2 in vitamin D receptor knock-out mice
- Open Access
- 1 January 2008
- Published by SAGE Publications in Gene Regulation and Systems Biology
- Vol. 2, 97-105
Calcitriol and TO-901317 Interact in Human Prostate Cancer LNCaP Cells
Vitamin D receptor (VDR) and liver X receptor (LXR) are nuclear receptors, which regulate gene transcription upon binding of their specific ligands. VDR seems to play a role in the regulation of prostate cancer cell proliferation. ATP-binding cassette transporter A1 (ABCA1) is known to be a target gene of LXR and it has been reported to be inhibited by androgen and to be involved in the regulation of LNCaP proliferation. We find that calcitriol (1α,25(OH)2D3) inhibits both basal and a LXR agonist, TO-901317, induced ABCA1 mRNA expression but has no effect on the mRNA expression of ATP-binding cassette transporter G1 (ABCG1), LXRα nor LXRβ TO-901317 increases both basal and calcitriol induced 25-hydroxyvitamin D3-24-hydroxylase (CYP24) mRNA expression and it slightly but significantly inhibits VDR mRNA expression. The inhibition of ABCA1 by calcitriol appears to be androgen-independent. Cell growth assay shows that when each of calcitriol and 5a-dihydrotestosterone (DHT) was co-treated with ABCA1 blocker, glybenclamide, cell-growth is significantly decreased compared to their own treatments respectively. Our study suggests a possible interaction between calcitriol and TO-901317 in LNCaP cells. Alike DHT, the inhibition of ABCA1 by calcitriol may be involved in its regulation of LNCaP growth.
- 1 January 2008
- Published by SAGE Publications in Gene Regulation and Systems Biology
- Vol. 2, 97-105
Open AccessCalcitriol and TO-901317 Interact in Human Prostate Cancer LNCaP Cells
Vitamin D receptor (VDR) and liver X receptor (LXR) are nuclear receptors, which regulate gene transcription upon binding of their specific ligands. VDR seems to play a role in the regulation of prostate cancer cell proliferation. ATP-binding cassette transporter A1 (ABCA1) is known to be a target gene of LXR and it has been reported to be inhibited by androgen and to be involved in the regulation of LNCaP proliferation. We find that calcitriol (1α,25(OH)2D3) inhibits both basal and a LXR agonist, TO-901317, induced ABCA1 mRNA expression but has no effect on the mRNA expression of ATP-binding cassette transporter G1 (ABCG1), LXRα nor LXRβ TO-901317 increases both basal and calcitriol induced 25-hydroxyvitamin D3-24-hydroxylase (CYP24) mRNA expression and it slightly but significantly inhibits VDR mRNA expression. The inhibition of ABCA1 by calcitriol appears to be androgen-independent. Cell growth assay shows that when each of calcitriol and 5a-dihydrotestosterone (DHT) was co-treated with ABCA1 blocker, glybenclamide, cell-growth is significantly decreased compared to their own treatments respectively. Our study suggests a possible interaction between calcitriol and TO-901317 in LNCaP cells. Alike DHT, the inhibition of ABCA1 by calcitriol may be involved in its regulation of LNCaP growth.
- 1 October 2007
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 107 (1-2) , 100-105
Regulation of 17β-hydroxysteroid dehydrogenase type 2, type 4 and type 5 by calcitriol, LXR agonist and 5α-dihydrotestosterone in human prostate cancer cells
- 1 October 2007
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 107 (1-2) , 100-105
Regulation of 17β-hydroxysteroid dehydrogenase type 2, type 4 and type 5 by calcitriol, LXR agonist and 5α-dihydrotestosterone in human prostate cancer cells
- 1 June 2006
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 345 (2) , 720-725
Regulation of cholesterol 25-hydroxylase expression by vitamin D3 metabolites in human prostate stromal cells
- 1 June 2006
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 345 (2) , 720-725
Regulation of cholesterol 25-hydroxylase expression by vitamin D3 metabolites in human prostate stromal cells